(Press-News.org) COLUMBUS, Ohio – Researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have identified an experimental agent that targets chronic lymphocytic leukemia and perhaps other proliferative disorders of lymphocytes.
Their study shows that the small-molecule inhibitor CAL-101 directly promotes cell death by apoptosis in chronic lymphocytic leukemia (CLL) cells and disrupts several external survival pathways needed for CLL cell viability and proliferation.
The agent blocks a molecule called PI3K-delta, an isomer of the PI3K (phosphatidylinositol-3 kinase) pathway, which is activated mainly in blood-forming, or hematopoietic, cells.
The research used cells from patient tumors and was posted recently in the journal Blood.
"Overall, our findings provide a rationale for the development of CAL-101 as the first in a new class of targeted therapies for CLL," says principal investigator Amy J. Johnson, assistant professor of hematology and medicinal chemistry, and a CLL researcher in the OSUCCC-James.
"A PI3K inhibitor hasn't been developed yet because this pathway is required for many essential cellular functions, but the identification of PI3K-delta, which is hematopoietic-selective, unlocks a potential new therapy for B-cell malignancies," Johnson says.
CLL is the most common from of adult leukemia in the United States, with about 15,000 new cases and 4,500 deaths annually. An estimated 100,760 people in the United States are living with or are in remission from CLL.
People with the asymptomatic phase of CLL can live many years, even without treatment. But once the disease progresses to its symptomatic phase, treatment is required. This is usually a chemotherapy-based regimen that often induces remission. But current therapies are not curative and nearly all patients relapse.
The PI3K pathway is essential for survival of cells generally. This made it an unsuitable target for small molecule inhibitors until recently when research showed that PI3K-delta expression occurs mainly in hematopoietic cell types. Preclinical studies suggest that blocking this molecule may kill B cells with little toxicity to other hematopoietic cells.
The present study, which used CLL cells from patients, found the following:
CLL cells show high PI3K pathway activity and PI3K-delta expression;
CAL-101 preferentially kills CLL cells compared to normal B-cells;
CAL-101 selectively inhibits PI3K-delta and directly promotes apoptosis in primary CLL cells, and it disrupts multiple external survival pathways;
CAL-101 cell killing is caspase dependent and not diminished by the presence of stromal cells;
CAL-101 does not kill normal T-cells or NK cells or reduce antibody-dependent cellular cytotoxicity, but it does lower production of inflammatory and anti-apoptotic cytokines by activated T-cells.
INFORMATION:Note: A phase I clinical trial (NCT00710528) of CAL-101 is currently under way in select relapsed or refractory hematologic malignancies at Ohio State and other centers.
Funding from the Leukemia and Lymphoma Society, The D. Warren Brown Foundation, and Calistoga Pharmaceuticals supported this research. Amy Johnson is a Paul Calabresi Scholar.
END
Washington, DC, SEPTEMBER 14, 2010– A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announced today that these same drugs – when used long term – may be related to unusual but serious fractures of the thigh bone. In the most comprehensive scientific report to date on the topic, the task force reviewed 310 cases of "atypical femur fractures," and found that 94 percent (291) of patients had taken the drugs, most for more than five years. The task force members emphasized that atypical ...
A set of studies released in this month's special issue of The Elementary School Journal reveals the powerful effect that the coaching of teachers can have on both teachers and students.
"Many in the field have trusted that intuitive feeling that putting a knowledgeable coach in a classroom to work with a teacher will result in improved teacher practices and increased student learning," write the issue's guest editors, Misty Sailors of The University of Texas at San Antonio and Nancy L. Shanklin of University of Colorado, Denver. "The jury of these researchers and the ...
Repairing small, seemingly benign holes in a child's heart may be more clinically important than previously thought, as dysfunction could be lurking out of sight. These are the findings from a study conducted by doctors and researchers at Nationwide Children's Hospital and the Ohio State University Medical Center examining a subset of the most common form of congenital heart disease, ventricular septal defect. The recently published study appears in the Journal of Molecular and Cellular Cardiology, the official journal of the International Society for Heart Research.
Ventricular ...
Years ago the idea of using a virtual data room (VDR) seemed like it would never be accepted. The concept of taking paper due diligence materials and placing them 'online' seemed too far fetched to work. People felt the internet would never have the level of security or the speed required to display sensitive corporate information to outside parties. Once internet connection speeds increased and security measures improved so did the idea of people reviewing information on a computer screen from the comfort of their own office. Today, VDR awareness is still growing and the ...
Caring Technologies Inc., developer of the proprietary Behavior Imaging technology, unveiled a new brand identity today, changing its name to Behavior Imaging Solutions, Inc. The timing coincides with its recent registered trademark award, and reflects the company's history and commitment to Behavior Imaging technology as a means of treating behavioral disorders with greater accuracy and cost-effectiveness. The company's rebranding effort is intended to establish broader market application of Behavior Imaging as an innovative and versatile solution for healthcare providers ...
When people hear the word hospice, visions of imminent death are conjured and fear of the unknown prevails in even the coolest of heads. While death is ultimately the inescapable result, Hospice focuses on life and making sure that every last moment can be lived to the fullest. Raleigh resident Bobbi Lancaster recently experienced first-hand the value and comfort Hospice of Wake County brings to not only the patient, but the family as well.
In a matter of months, Lancaster was nearly consumed by a maelstrom of events that threatened to drag her under including the loss ...
Njideka Harry, Founder & Executive Director of Youth for Technology Foundation (YTF), received a nomination for this year's 2010 Microsoft Integral Fellows Award. The Microsoft Alumni Foundation gives this award to "recognize and support a Microsoft alumnus who has made a meaningful difference in the daily lives of others by using his/her talents, time and resources to contribute to the world."
Up to four alumni nominees for the Microsoft Integral Fellows Award will receive a $25K award to go to the 501(c)(3) with which they work in the form of a one-year, unrestricted ...
Letetia Mullenix, founder of Families with Faith joins 'Out the Box' Monday, September 13th at 8PM to discuss her new book, "Promise Road: Walking through the Process that Manifests the Promise".
Promise Road offers its readers an original and fresh approach on awaiting the promises of God during difficult seasons. The book chronicles the season in the author's life that God used to manifest His promise for personal and marital restoration. While imparting biblical insight regarding the promises of God, Promise Road offers hope to all who stand in need of restoration. ...
Industry professionals from around the world can now nominate their favorite company or individual for the Perspective Magazine "Best in the World" Awards Program in conjunction with GNEX 2011.
Categories range across the full spectrum of the industry, from "Best Timeshare Resort" and "Best Marketing Team" through to "Best Individual Professional". Among the award categories are opportunities for green initiatives, innovation and technology awards, an entrepreneur award and even a best newcomer award for the best new entrant to the industry.
Nominations will be ...
Tin-va Latin, LLC is launching a new and revolutionary cardio dance workout program called La Tin-Va Fitness!
Discover the La Tin-Va experience at the Blackbird Dance Company, 6767 West Sunset Blvd, Hollywood, CA 90028. The classes will be held every Tuesday from 6:30 p.m. - 7:30 p.m. Call us at (323) 205-6579 or email us at vip@latinva.com to reserve your spot by leaving your full name and contact information.
Learn new Latin cardio dance routines inspired by Cha Cha, Salsa, Merengue, Tango and Mambo. From the Fitness Club to the Dance Club, come and join the party ...